Brief: China Traditional Chinese Medicine Says Unit To Sell Stake In Sinopharm Group Guizhou Blood Products
Oct 9 (Reuters) - China Traditional Chinese Medicine
Holdings Co Ltd 0570.HK :
* ANNOUNCES DISPOSAL OF 20% EQUITY INTEREST IN SINOPHARM
GROUP
GUIZHOU BLOOD PRODUCTS COMPANY
* DEAL FOR RMB90.6 MILLION
Source text for Eikon: ID:nHKS9HGhjn
Further company coverage: 0570.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Traditional Chinese Medicine Holdings
See all newsBrief: China Traditional Chinese Medicine Says Subsidiaries Enter Contracts
Brief: China Traditional Chinese Medicine Holdings Says NMPA Approves Xingpi Jieyu Tablets For Marketing
China Traditional Chinese Medicine H1 revenue falls on decline across segments
Brief: China Traditional Chinese Medicine Expects Loss Of RMB800 Mln-RMB850 Mln For HY
Brief: China Traditional Chinese Medicine Says Yang Jun Resigns As Executive Director And Chairman